<DOC>
	<DOCNO>NCT02359903</DOCNO>
	<brief_summary>ASART-1 clinical study phase 1 study carry establish pharmacokinetic equivalence equal safety profile BCD-055 ( infliximab manufacture JSC BIOCAD , Russia ) Remicade use multiple IV infusion treatment ankylose spondylitis .</brief_summary>
	<brief_title>Comparative Evaluation Pharmacokinetics Safety BCD-055 Remicade Patients With Ankylosing Spondylitis</brief_title>
	<detailed_description>ASART-1 study first step clinical evaluation infliximab biosimilar manufacture JSC BIOCAD , Russia.The aim study establish BCD-055 equivalent Remicade term pharmacokinetics safety use standard regimen patient ankylose spondylitis ( AS ) . The study enroll 90 patient active AS , randomize 2 group ( 1:1 ratio ) : patient first group receive BCD-055 IV dose 5 mg/kg week 0 , 2 , 6 , 14 22 ; patient second group receive Remicade regimen .</detailed_description>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>sign informed consent active ankylosing spondylitis , exist patient within last 3 month BASDAI score &gt; equal 4 point , spinal pain ( VAS ) &gt; equal 4 point history NSAID use treatment AS within last 3 month adequate renal liver function absence severe abnormality complete blood count consent use adequate contraception ability follow Protocol procedure previously use biologic AS treatment total ankylosing spine know allergy chimeric protein excipients BCD055/Remicade hepatitis B , active hepatitis C , HIV , syphilis know tuberculosis latent form tuberculosis bacterial infection diagnose within last month require oral antibiotic ( within last 2 week ) parenteral antibiotic ( within last 4 week ) drug alcohol abuse disease affect assessment mask symptom AS ( severe osteoarthrosis , nervous disorder impairment sensory motor function , another inflammatory joint disease apart AS , etc . ) severe uncontrolled hypertension chronic heart failure decompensated renal liver disorder severe uncontrolled diabetes mellitus chronic obstructive lung disease , atopic bronchial asthma , angioedema anamnesis mental disorder , incl . severe depression or/and suicide thoughts/actions anamnesis unstable angina pectoris myocardial infarction within last 12 month Other exclusion criterion could find Full Study Protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>